source
- Apnimed secures $192 million IPO to fund sleep-apnea drug program targeting 2027 launchApnimed, a biotech focused on sleep apnea, announced it raised $192 million through an initial public offering. The capital will be used to advance its lead drug candidate, with plans to begin a l…
- Senate advances Erica Schwartz’s CDC director nomination to full Senate voteThe Senate Health Committee approved Erica Schwartz as the nominee for CDC director, securing bipartisan support that included every Republican member and Democrat Tim Kaine. With the committee’s…